Table 1.
Cofactor | Fold discrimination |
---|---|
l-Histidine methyl ester | 1.1 |
l-Histidine benzyl ester | 1.3 |
α-Methyl-dl-histidine | 24 |
l-Histidinamide | 41 |
Glycylhistidine | 185 |
l-Histidinol | 357 |
3-Methyl-l-histidine | 455 |
d-Histidine | 714 |
l-β-Imidazolelactic acid | 1,235 |
1-Methyl-l-histidine | 1,250 |
Histamine | 5,263 |
Imidazole | 6,667 |
Urocanic acid | >10,000 |
dl-1′,2′,4′-Triazolyl-3-alanine | >10,000 |
β-2-Thienyl-l-alanine | >10,000 |
Imidazole-4-acetic acid | >10,000 |
In general, deoxyribozyme activity diminishes in proportion to the level of disruption of the carboxyl and amino groups of l-histidine. Samples of 1- and 3-methyl-l-histidine may contain as much as 10 μM unmodified l-histidine as a contaminant. This concentration of preferred cofactor is more than sufficient to produce the level of HD2 activity seen with these analogs.